Updated on 2022/12/02

写真a

 
HISANO Fumiya
 
Organization
Graduate School of Medicine Assistant Professor
Undergraduate School
School of Health Sciences
Title
Assistant Professor
External link

Degree 2

  1. 博士(看護学) ( 2021.3   名古屋大学 ) 

  2. 修士(看護学) ( 2018.3   名古屋大学 ) 

Research Interests 2

  1. リンパ浮腫ケア

  2. リンパ浮腫ケア

Research History 1

  1. Nagoya University   Assistant Professor

    2021.5

Education 2

  1. Nagoya University

    2016.4 - 2021.3

  2. Nagoya University

    2009.4 - 2013.3

Professional Memberships 6

  1. 日本看護医療学会

    2022

  2. 国際リンパ浮腫フレームワークジャパン研究協議会

    2022

  3. リンパ学会会員

    2017

  4. 看護技術学会会員

    2015

  5. 看護科学学会会員

    2015

▼display all

 

Papers 10

  1. A Pilot Study of Determining the Reliability of a New Three-Dimensional Scanning System for Measuring Truncal Thickness After Breast Cancer Surgery

    Hisano Fumiya, Watanabe Sachiyo, Niwa Shiori, Nakanishi Keisuke, Mawaki Ayana, Takeno Yukari, Murota Kaoru, Honda Ikumi, Fujimoto Etsuko, Oshima Chika

    LYMPHATIC RESEARCH AND BIOLOGY     2022.9

     More details

  2. EFFICACY AND SAFETY OF LONG-TERM ADMINISTRATION OF PEMAFIBRATE, A NOVEL HYPOTRIGLYCERIDEMIC AGENT, IN JAPANESE TYPE 2 DIABETIC PATIENTS RECEIVING A STATIN

    Kusunoki M., Wakazono N., Matsuda S., Hisano F., Miyata T.

    ATHEROSCLEROSIS   Vol. 355   page: E267 - E268   2022.8

     More details

    Language:Japanese  

    Web of Science

  3. Influence of Age on the Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients With Type 2 Diabetes Mellitus

    Kusunoki Masataka, Hisano Fumiya, Matsuda Shinichi, Wakazono Naomi, Tsutsumi Kazuhiko, Miyata Tetsuro

    JOURNAL OF ENDOCRINOLOGY AND METABOLISM   Vol. 12 ( 2 ) page: 53 - 58   2022.4

     More details

    Language:Japanese  

    DOI: 10.14740/jem799

    Web of Science

  4. Effect of Treatment With Sodium-Glucose Cotransporter 2 Inhibitor on the Initiation of Continuous Positive Airway Pressure Therapy in Type 2 Diabetic Patients With Obstructive Sleep Apnea Syndrome Reviewed

    Kusunoki M, Hisano F, Wakazono N, Tsutsumi K, Oshida Y, Miyata T

    Journal of Clinical Medicine Research   Vol. 13 ( 10-11 ) page: 497 - 501   2021.11

     More details

    Language:English   Publisher:Journal of Clinical Medicine Research  

    Background: Obese patients with type 2 diabetes mellitus often develop obstructive sleep apnea syndrome (OSAS). In this study, continuous positive airway pressure (CPAP) was initiated in Japanese patients with type 2 diabetes mellitus who developed OSAS during treatment with a sodium-glucose cotransporter 2 (SGLT2) inhibitor, and the effect of the SGLT2 inhibitor therapy on the patients was investigated. Methods: The study was conducted in outpatients with type 2 diabetes mellitus with serum hemoglobin A1c (HbA1c) values of ≥ 6.5% who developed OSAS. The patients were divided into two groups according to whether they were receiving treatment with an SGLT2 inhibitor or with other oral hypoglycemic agents: the SGLT2 inhibitor group (n = 9) and non-SGLT2 inhibitor group (n = 7). The patients in the former group were under treatment with one of the following three SGLT2 inhibitors: luseogliflozin (2.5 mg/day), dapagliflozin (5 mg/day) and empagliflozin (10 mg/day). The patients took the drugs once daily, before or after breakfast. The patients were initiated on CPAP therapy for OSAS, and their weight, body mass index (BMI), serum HbA1c level, lipid profile, liver function parameters, serum uric acid, and apnea-hypopnea index (AHI) measured before the initiation of CPAP therapy (baseline) were compared with the values measured 3 months after the start of CPAP therapy. Results: The AHI decreased significantly after 3 months of CPAP therapy, as compared to that at the baseline, in both the SGLT2 inhibitor and non-SGLT2 inhibitor groups. There was no significant change in the serum HbA1c value after 3 months of CPAP therapy as compared to that at the baseline in either group. The body weight and BMI increased significantly after 3 months of CPAP therapy in the SGLT2 inhibitor group, but not in the non-SGLT2 inhibitor group. Conclusion: The body weight and BMI increased significantly after 3 months of CPAP therapy initiated for OSAS in the type 2 diabetic patients who were receiving SGLT2 inhibitor therapy. Thus, when CPAP therapy is adopted for an obese diabetic patient with OSAS, it should be borne in mind that the body weight may increase if the patient is receiving SGLT2 inhibitor treatment.

    DOI: 10.14740/jocmr4626

    Scopus

    PubMed

    researchmap

  5. The Correlation Between Fluid Distribution and Swelling or Subjective Symptoms of the Trunk in Lymphedema Patients: A Preliminary Observational Study Reviewed

    Hisano Fumiya, Niwa Shiori, Nakanishi Keisuke, Mawaki Ayana, Murota Kaoru, Fukuyama Atsushi, Takeno Yukari, Watanabe Sachiyo, Fujimoto Etsuko, Oshima Chika

    LYMPHATIC RESEARCH AND BIOLOGY   Vol. 19 ( 3 ) page: 269 - 273   2021.6

     More details

    Authorship:Lead author   Language:Japanese   Publisher:Lymphatic Research and Biology  

    Background: Manual lymph drainage (MLD) is one of the common treatments for breast cancer-related lymphedema (BCRL). Although the primary goal of MLD is to drain the excessive fluid accumulated in the affected upper limb and trunk to an area of the body that drains usually, the use of MLD is decided based on swelling and subjective symptoms, without assessing whether there is fluid accumulated in the affected region. The purpose of this study was to examine truncal fluid distribution in a sample of BCRL patients and investigate any correlation between such fluid distribution and swelling or subjective symptoms. Methods and Results: An observational study was conducted with 13 women who had unilateral, upper extremity BCRL. Fluid distribution was evaluated by using two magnetic resonance imaging (MRI) sequences: half-Fourier acquisition single-shot turbo spin echo and three-dimensional double-echo steady-state. The presence of swelling was determined by lymphedema therapists, and subjective symptoms were measured by using a visual analog scale. On MRI, no participants had any free water signals in the trunk. However, seven had swelling and all 13 had some kind of subjective symptoms on the affected side of their trunk. Conclusions: These results suggest that swelling and subjective symptoms do not correlate with the presence of truncal fluid. For such cases, a different approach than MLD may be needed to address truncal swelling and related subjective symptoms. Checking for the presence of fluid in the truncal region may help MLD be used more appropriately.

    DOI: 10.1089/lrb.2020.0075

    Web of Science

    Scopus

    PubMed

    researchmap

▼display all

Presentations 18

  1. リンパ浮腫ケアのエビデンス確立を目指した研究活動の紹介

    大島千佳、丹羽史織、久野史椰、渡邉幸代、中西啓介、間脇彩奈、竹野ゆかり、藤本悦子

    第5回日本リンパ浮腫学会総会  2022.3.11 

     More details

    Event date: 2022.3

    Presentation type:Symposium, workshop panel (nominated)  

  2. 乳がん術後リンパ浮腫患者の体幹部における形態的特徴-3Dスキャナーの計測値と現状の評価指標との比較-

    久野史椰, 丹羽史織, 渡邉幸代, 中西啓介, 間脇彩奈, 竹野ゆかり, 本田育美, 藤本悦子, 大島千佳.

    第41回日本看護科学学会学術集会  2021.12.4 

     More details

    Event date: 2021.12

    Language:Japanese   Presentation type:Oral presentation (general)  

  3. 乳がん治療関連リンパ浮腫患者の中高強度身体活動の実態に関する研究

    中西 啓介, 間脇 彩奈, 丹羽 史織, 久野 史椰, 竹野 ゆかり, 渡邉 幸代, 大島 千佳, 藤本 悦子

    第43回日本看護科学学会学術集会  2021.12.4 

     More details

    Event date: 2021.12

    Language:Japanese   Presentation type:Oral presentation (general)  

  4. 乳がん術後リンパ浮腫患者の水分貯留と水分分布状況

    丹羽史織, 間脇彩奈, 久野史椰, 中西啓介, 竹野ゆかり, 渡邉幸代, 藤本悦子, 大島千佳.

    第42回日本看護科学学会学術集会  2021.12.4 

     More details

    Event date: 2021.12

    Language:Japanese   Presentation type:Oral presentation (general)  

  5. 乳がん手術後のリンパ浮腫に対する早期発見プログラムの構築

    久野史椰, 丹羽史織, 大島千佳

    令和3年度第1回脳とこころの研究センタープログレスレポート会議 

     More details

    Event date: 2021.11

    Presentation type:Oral presentation (general)  

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 1

  1. リンパ浮腫患者の体幹部測定方法確立に向けた基礎研究 -3Dスキャナーを用いて-

    Grant number:21K21164  2021.8 - 2023.3

    科学研究費助成事業  研究活動スタート支援

    久野 史椰

      More details

    Authorship:Principal investigator 

    Grant amount:\2080000 ( Direct Cost: \1600000 、 Indirect Cost:\480000 )

    本研究は乳がん術後リンパ浮腫患者の効果的な体幹部のケア開発をめざした基礎研究である。乳がん術後リンパ浮腫は、患側上肢に浮腫が生じることが知られるが、患側上肢周辺の体幹部にも浮腫をもたらす症例の存在が報告されている。一方で、体幹部の浮腫を定量的に測定した研究報告はほとんどない。
    そこで本研究では、乳がん術後リンパ浮腫患者の体幹部の測定方法の確立を念頭に、その基礎段階として、3Dスキャンシステムを用いた体幹部測定を試み、その精度を解析する。3Dスキャンシステムは、非接触のもとに3次元データの取得が可能で、体幹の腫脹を簡便に定量化できる。